Video

This webinar teaches practical trauma-informed strategies to engage with and enhance care for patients with SUDs.

This webinar reviews the state of the science of digital therapeutics for behavioral health and timely opportunities to scale up access to digital health tools, including those related to substance use, via multiple paths to deployment around the world.

This webinar discusses scientific evidence regarding digital peer support services including telephone-based, video games, and smartphone app peer support services, the current landscape of offerings within the United States, how to select technologies that promote recovery, and ethical challenges/opportunities to the future of peer support.

This webinar discusses the uses and benefits of technology-assisted care and how it can be used to increase the effectiveness and reach of treatment for substance use disorders.

Presents information about the benefits of behavioral health and primary care integration for improving the health and well-being of communities, including a discussion about potential federal policy opportunities

Nurse Practitioner Vanessa Loukas, a PCSS expert, discusses the issue of stigma in treating patients with opioid use disorder (OUD)—from the patients to the providers who treat them.

This was a virtual public workshop to discuss a practical research agenda toward treatment development for stimulant use disorder. Meeting participants responded to a proposed practical research agenda that focuses on innovation in clinical trial design and candidate endpoints for the evaluation of potential treatments for stimulant use disorder.

This two-day public workshop convened regulators, academic researchers, clinicians, patient advocates, and other stakeholders to share information underlying this action and gather input related to the safe use of benzodiazepines.

This was a two-day virtual public workshop (which can now be re-watched) that focused on identifying gaps in existing opioid prescriber education offerings and core competencies that should be included in educational content for opioid prescribers and other healthcare providers, including prescriber education under a Risk Evaluation and Mitigation Strategy (REMS).

This was a two-day virtual public workshop (which can now be re-watched) that convened regulators, clinical researchers, providers, patient advocates, and other stakeholders to exchange information and obtain input by discussing prescriber education's potential role in alleviating the evolving opioid and substance use crisis.